New York, NY -- (SBWIRE) -- 01/08/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: ZIOPHARM Oncology Inc (NASDAQ:ZIOP), American Superconductor Corporation (NASDAQ:AMSC), Vonage Holdings Corp (NYSE:VG), Lexicon Pharmaceuticals, Inc (NASDAQ:LXRX)
ZIOPHARM Oncology Inc (NASDAQ:ZIOP) showed a volume of 1.16 million shares by the end of last trade whereas the average volume of the stock remained 1.21 million shares. The stock opened the session at $4.30 but then moved to $4.14. At that price, the stock showed a negative performance of -3.04%. ZIOPHARM Oncology, Inc., is a biotechnology company. The Company employs gene expression and control technology to deliver deoxyribonucleic acid (DNA) for the treatment of cancer. The Company's technology employs Intrexon Corporation's RheoSwitch Therapeutic System to turn on and off, and precisely modulate, gene expression at the cancer site in order to improve the therapeutic index. As of October 18, 2013, the technology was being evaluated in Phase II clinical studies of the immune system cytokine interleukin-12 for the treatment of breast cancer and advanced melanoma.
Will ZIOP Get Buyers Even After The Recent Rally? Find Out Here
American Superconductor Corporation (NASDAQ:AMSC) opened the session at $1.64and closed the session at $1.68. The stock showed a positive performance of 2.44% in previous trading session. American Superconductor Corporation (AMSC) is a provider of megawatt-scale solutions that lower the cost of wind power and enhance the performance of the power grid. It operates in two business units: Wind and Grid. Wind business segment enables manufacturers to field wind turbines with power output, reliability and affordability. Grid business segment enables electric utilities and renewable energy project developers to connect, transmit and distribute power with efficiency, reliability and affordability. The Company’s wind and power grid products and services provide reliability, security,
For How Long AMSC will fight for Profitability? Read This Trend Analysis report
Vonage Holdings Corp (NYSE:VG) opened the session at $3.27 and closed the session at $3.28. The stock showed a positive performance of 0.31% in previous trading session. The beta of the stock remained 1.78. Vonage Holdings Corp. (Vonage) is a provider of communications services connecting people through broadband devices worldwide. The Company’s network include session initiation protocol (SIP) based voice over Internet protocol (VoIP), network on the Internet. The platform enables a user via a single identity, either a number or user name, to access and utilize services and features regardless of how they are connected to the Internet, including over third generation (3G), fourth generation (4G), cable, or digital subscriber line (DSL) broadband networks. Through this technology,
Why Should Investors Buy VG After The Recent Gain? Just Go Here and Find Out
Lexicon Pharmaceuticals, Inc (NASDAQ:LXRX) the stock decreased -0.56% and finished the session at $1.76. Traded with volume of 1.13 million shares in the prior session and the average volume of the stock remained 1.38 million shares. The beta of the stock remained 2.08. Lexicon Pharmaceuticals, Inc. (Lexicon Pharmaceuticals) is a biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease. Lexicon Pharmaceuticals uses its gene knockout technologies and an integrated platform of medical technologies to study the physiological and behavioral functions of almost 5,000 genes in mice and assessed the utility of the proteins encoded by the corresponding human genes as drug targets.
Will LXRX Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)